Lynozyfic received FDA accelerated approval for relapsed/refractory multiple myeloma, showing a 70% response rate in trials, but carries a boxed warning for severe side effects. CAR T-cell therapy is ...

(WSET) — Sinclair Cares is partnering with the American Cancer Society to help drive out cancer. There are multiple resources and programs that help cancer patients. Every person touched by cancer is ...

University of Kentucky Markey Cancer Center researchers have identified a protein that could be a promising treatment target for obesity-related breast cancer. "The findings could eventually lead to ...

Researchers at the Fred Hutchinson Cancer Research Center found that autoantibodies targeting the exoproteome reshaped checkpoint inhibitor responses and opened new avenues to enhance immunotherapy.

“Winning the war on cancer” (July 19th) was a welcome and thoughtful overview, highlighting the tangible benefits of cancer prevention and even daring to address the frontier science of personalised ...